
Uppsala Reports editor
@UMCGlobalSafety
In this digital age, can pharmacovigilance experts leverage on new types of data to find evidence for signals? Listen to the latest Drug Safety Matters podcast to find out.
Spontaneous adverse drug reaction reports have been the proverbial ‘bread and butter’ for signal detection since the beginnings of pharmacovigilance. But times are changing, and with the abundance of data now available in a society that has gone digital, it is time to explore new data sources to detect signals.
Join Federica Santoro and Daniele Sartori, a pharmacovigilance scientist at UMC and doctoral researcher at the University of Oxford, discuss expanding sources of evidence for more reliable signal detection.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.
Research / 15 November 2023
Herbals have been our go-to remedy for thousands of years, so why is it that we still know so little about their side-effects compared to modern medicines?
Research / 02 October 2023
Pregnancy and breastfeeding can be a chaotic period, exacerbated by lack of safety information for drugs taken during this time. The IMI ConcePTION project aims to change that.
Research / 17 October 2023